We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Onzima Ventures | LSE:ONZ | London | Ordinary Share | GB00BYQCDH57 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/9/2016 10:43 | 06/09/2016 10:38am UK Regulatory (RNS & others) TIDMONZ Onzima Ventures PLC ("Onzima" or the "Company") Investee company N4 Pharma announces formation of scientific advisory panel N4 Pharma Limited ("N4 Pharma"), in which Onzima holds a 49% equity stake, has announced that its intellectual property partner OPAL IP has formed a scientific advisory panel to provide advice and guidance on N4 Pharma's reformulation projects, the first of which is its reformulation of sildenafil. The panel is made up of Professor Karrar Khan, formerly Head of Pharmaceutical Development for Boots Pharmaceuticals and Knoll, Doctor David Templeton, an expert in pharmacokinetics and translational science, and Doctor Sean McCrossen, an expert in pharmaceutical development. N4 Pharma CEO Nigel Theobald commented: "This is a very strong advisory panel which together brings over 90 years' experience to our development programs. It will be a huge asset to help make sure that our reformulations meet the requirements of industry and the regulators and we are delighted that OPAL IP has been able to put together such a strong team." | someuwin | |
03/9/2016 15:51 | Great end to the week Let's see if this momentum can carry through. Over 2.2m buys Friday with little sign of any sellers. I think we have exhausted our sellers now at these levels. Likely a lot of the free float is in safe hands. Long period of consolidation that led to a very tight channel and now a sharp break out. We may need news to get above the 2p level but a strong move to that point could now be on. | keya5000 | |
02/9/2016 15:55 | Stock just got very tight. | keya5000 | |
02/9/2016 15:46 | Difficult to buy any - not surprising really. | someuwin | |
02/9/2016 15:17 | Someone in a hurry to snap a few up today. | keya5000 | |
02/9/2016 14:40 | Can not be far off now for news someuwin, process of finding a partner started in May so we are now four months in. There is also the other pharma investment that they eluded to. Rumours it is the ibuprofen patch developer Medherant. NT is a director of the above company and they are seeking investment to take a well developed product further to market; Final Results extract; In order to diversify the portfolio we have also taken a significant stake in N4 Pharma Limited, an early stage but very exciting company within the pharmaceutical space. The market has reacted well to this position and we plan in due course to increase our exposure to this sector. We believe that we are well placed to make some new and exciting investments and are already in discussions with a view to adding to the portfolio. | keya5000 | |
02/9/2016 13:07 | Good to see interest picking up here. News on N4 developments must be close. | someuwin | |
01/9/2016 08:11 | 200k buy ISDX, they are nibling them up at these levels that's for sure. | keya5000 | |
01/9/2016 07:09 | Agree ST we must be getting into the news zone soon. | keya5000 | |
01/9/2016 07:03 | Barrie... all imvho... but I feel it has been a long time since news... we have consolidated nicely and I just feel this is the calm before the storm. | sophisticatedtrader | |
31/8/2016 17:14 | Only on AIM two buys to every sell and it's down. | keya5000 | |
31/8/2016 17:08 | sophisticatedtrader why is now the time for onwards and upwards? | barrie16 | |
31/8/2016 12:35 | Onwards and upwards now imvho | sophisticatedtrader | |
30/8/2016 16:11 | Nice flurry of buys there, whose been helping themselves to the cheap ones then? | keya5000 | |
30/8/2016 14:25 | Bit more volume today, only a matter of time. | keya5000 | |
30/8/2016 00:01 | Keya5000 These boards have some very weird posters these days (GKP a case in point]. What happened to the ordinary shareholder asking pertinent questions? | barrie16 | |
29/8/2016 21:33 | Barrie, all very weird. Personally I think he got warned off by the company, he had a clear agenda andleft in a very strange manner hence I think it was a polite request to shut the f@ck up or face further action. | keya5000 | |
23/8/2016 20:34 | After weeks of aggressive verbal posts from Fido, outlining the way ONZ's Future was going to pan out, he posted his last thread On the 2nd August, he gave a very contrite fare well post wishing all shareholders and posters on this board the 'very best of luck' the shares haven't done much since, in fact they have been very quiet. Is this the Fido effect! Who was he!!! does anyone know, was he part of the company. Did he have an agenda? | barrie16 | |
19/8/2016 17:02 | Perhaps the GM caused the excitement ... | jakleeds | |
19/8/2016 14:25 | Agree something seems to be moving this today. No sells and 1.4m buys. Very interesting. | keya5000 | |
19/8/2016 14:24 | Agree something seems to be moving this today. No sells and 1.4m buys. Very interesting. | keya5000 | |
19/8/2016 14:24 | MM's seem very short of stock, they won't even deal in 50K normal market size chunks anymore. Tried a 50K fill or kill and it was refused. | simonparker5 | |
19/8/2016 14:19 | Good volume today ... thought we could be in for a blue day! ;-))) | sophisticatedtrader | |
19/8/2016 13:26 | Timing is everything here and this could be a really time to get in or back in. News on N4 is long over due and could land at any-time now we have the GM out of the way. | simonparker5 | |
19/8/2016 13:19 | N4 are not lazing around on the beach.They are busy building a significant Pharma co. | someuwin |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions